Multicenter, Double-Blind, Parallel, Placebo-Controlled, Randomised Phase 3 Study of Etanercept in the Treatment of Patients With Ankylosing Spondylitis: 12-Week Final Data
收藏DataCite Commons2025-10-02 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00006769/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The primary objective of the study was to compare the efficacy of etanercept (25 mg, twice
weekly) with that of placebo based on the percentage of patients who achieve the Assessment
in Ankylosing Spondylitis (ASAS) response criteria (ASAS 20%) at week 12.
提供机构：
Vivli
创建时间：
2021-04-02
